Neos Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
22 Mar 2019	Form 3: Limongelli John M, SVP & General Counsel No securities owned
30 Jan 2019	Form 3: Robinson James A. Jr., Director No securities owned
28 Jun 2018	Form 3: McLaughlin Gerald W., Director No securities owned
01 May 2018	Form 3: Szyper Linda M, Director
17 Feb 2017	Form 3: Schuler Jack W, 10% owner Holds 2,338,671 shares of Common Stock
01 Jun 2016	Form 3: Martens Juergen, Chief Tech/Operations Officer No securities owned
03 Sep 2015	Form 3: Hecht Beth, Director No securities owned
23 Jul 2015	Form 3: Bluhm Andrew G, 10% owner and 5 others
22 Jul 2015	Form 3: Heller Alan L, Director Holds 110,151 shares of Common Stock
22 Jul 2015	Form 3: Engelking Dorothy, VP, Regulatory Affairs
22 Jul 2015	Form 3: Fong Bryant, Director No securities owned
22 Jul 2015	Form 3: Schmid John P., Director
22 Jul 2015	Form 3: Iannelli Ralph, 10% owner and 1 other Holds 7,289 shares of Common Stock
22 Jul 2015	Form 3: Edick Paul R, Director
22 Jul 2015	Form 3: Kearny Venture Assoicates Ii Llc, 10% owner and 3 others
22 Jul 2015	Form 3: Robitaille Gregory J, Director Holds 25,710 shares of Common Stock
22 Jul 2015	Form 3: Tengler Mark, Chief Technology Officer Holds 109,560 shares of Common Stock
22 Jul 2015	Form 3: Schuler Jack W, 10% owner
22 Jul 2015	Form 3: Eisenstadt Richard I, Chief Financial Officer
22 Jul 2015	Form 3: McDonnell Thomas P, Chief Commercial Officer

Comments